Integrated Diagnostics Holdings plc
Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron… Read more
Integrated Diagnostics Holdings plc (IDGXF) - Total Assets
Latest total assets as of June 2025: $7.50 Billion USD
Based on the latest financial reports, Integrated Diagnostics Holdings plc (IDGXF) holds total assets worth $7.50 Billion USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Integrated Diagnostics Holdings plc - Total Assets Trend (2012–2024)
This chart illustrates how Integrated Diagnostics Holdings plc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Integrated Diagnostics Holdings plc - Asset Composition Analysis
Current Asset Composition (December 2024)
Integrated Diagnostics Holdings plc's total assets of $7.50 Billion consist of 43.2% current assets and 56.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 16.7% |
| Accounts Receivable | $930.31 Million | 13.1% |
| Inventory | $317.56 Million | 4.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $460.03 Million | 6.5% |
| Goodwill | $1.35 Billion | 18.9% |
Asset Composition Trend (2012–2024)
This chart illustrates how Integrated Diagnostics Holdings plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Integrated Diagnostics Holdings plc's current assets represent 43.2% of total assets in 2024, an increase from 17.3% in 2012.
- Cash Position: Cash and equivalents constituted 16.7% of total assets in 2024, up from 13.7% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 24.0% of total assets, a decrease from 74.0% in 2012.
- Asset Diversification: The largest asset category is goodwill at 18.9% of total assets.
Integrated Diagnostics Holdings plc Competitors by Total Assets
Key competitors of Integrated Diagnostics Holdings plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Integrated Diagnostics Holdings plc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Integrated Diagnostics Holdings plc generates 0.80x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Integrated Diagnostics Holdings plc generates $ 15.11 in net profit.
Integrated Diagnostics Holdings plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.53 | 1.59 | 1.65 |
| Quick Ratio | 1.37 | 1.32 | 1.48 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.20 Billion | $ 1.01 Billion | $ 439.59 Million |
Integrated Diagnostics Holdings plc - Advanced Valuation Insights
This section examines the relationship between Integrated Diagnostics Holdings plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.87 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 23.6% |
| Total Assets | $7.13 Billion |
| Market Capitalization | $74.41 Million USD |
Valuation Analysis
Below Book Valuation: The market values Integrated Diagnostics Holdings plc's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Integrated Diagnostics Holdings plc's assets grew by 23.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Integrated Diagnostics Holdings plc (2012–2024)
The table below shows the annual total assets of Integrated Diagnostics Holdings plc from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $7.13 Billion | +23.55% |
| 2023-12-31 | $5.77 Billion | +8.95% |
| 2022-12-31 | $5.30 Billion | -15.07% |
| 2021-12-31 | $6.24 Billion | +49.28% |
| 2020-12-31 | $4.18 Billion | +11.24% |
| 2019-12-31 | $3.76 Billion | +9.37% |
| 2018-12-31 | $3.43 Billion | +10.35% |
| 2017-12-31 | $3.11 Billion | +2.17% |
| 2016-12-31 | $3.05 Billion | +22.65% |
| 2015-12-31 | $2.48 Billion | +11.10% |
| 2014-12-31 | $2.24 Billion | -2.14% |
| 2013-12-31 | $2.28 Billion | -6.51% |
| 2012-12-31 | $2.44 Billion | -- |